ACADIA Pharmaceuticals to Present at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference on October 26, 2004
SAN DIEGO, Oct 19, 2004 /PRNewswire-FirstCall via COMTEX/ — ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that Uli Hacksell, Ph.D., Chief Executive Officer, will present at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference on October 26, 2004, at 3:50 pm Eastern Time at the Waldorf=Astoria Hotel in New York City.
A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investor relations section and an archived recording will be available on the website through November 9, 2004.
About ACADIA Pharmaceuticals
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA currently has five drug programs in clinical and preclinical development directed at large unmet medical needs and major commercial markets, including Parkinson’s disease, schizophrenia, chronic pain, and glaucoma. Using its proprietary drug discovery platform, ACADIA has discovered all of the drug candidates in its product pipeline. ACADIA’s headquarters and biology research facilities are located in San Diego, California and its chemistry research facilities are located in Copenhagen, Denmark.
ACADIA Pharmaceuticals Inc.
Thomas H. Aasen, Vice President and Chief Financial Officer